Salvage low dose rate brachytherapy for prostate cancer recurrence following definitive external beam radiation therapy

Intraprostatic local failure following primary external beam radiation therapy (RT) for prostate cancer remains a challenging clinical scenario. While multiple local therapy options have been proposed, no treatment has emerged as standard owing largely to concerns regarding increased toxicity and poor outcomes [1 –5]. As a result, many are unfortunately relegated to life-long androgen deprivation therapy (ADT), which is exclusively palliative in nature and itself bears substantial morbidity [6–8].

Source: Radiotherapy and Oncology - October 16, 2020 Category: Radiology Authors: William H. Smith, Jamie Cesaretti, Chih Peng Chin, Mitchell Terk, Richard G. Stock Tags: Original Article Source Type: research